Independent educationNo sales. No dosing. Sources on every brief.

Exact claim · Version 1 · Reviewed 2026-07-23

“More intensive insulin treatment is always better.”

A verdict on this wording and scope, not a universal grade for Insulin.

01 · Verdict

Misleading

The DCCT found important complication reductions alongside substantially more severe hypoglycemia. Treatment intensity must be individualized and monitored.

Evidence basis
Randomized human outcomes
Scope
The monitored intensive-treatment strategy and type 1 diabetes population studied in the DCCT.
Category
Clinical outcomes

02 · Primary record

Check the attached evidence

Editorial review
Internal editorial review recorded
Responsible editor
Anthony Treviso · Founder and responsible editor
Clinical-review boundary
Not independently medically reviewed.